GLENMARK PHARMGLENMARK PHARMGLENMARK PHARM

GLENMARK PHARM

No trades
See on Supercharts

Price target

1164.800.00 0.00%
The 10 analysts offering 1 year price forecasts for GLENMARK have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to GLENMARK in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

GLENMARK EPS for the last quarter is −28.20 INR despite the estimation of 5.50 INR. In the next quarter EPS is expected to reach 12.74 INR. Track more of GLENMARK PHARM financials and stay on top of what is up with the company.
In the next quarter GLENMARK PHARM revenue is expected to reach ‪37.79 B‬ INR. Check out GLENMARK PHARM revenue and earnings and make informed decisions.
According to analysts, GLENMARK price target is 1164.80 INR with a max estimate of 1412.00 INR and a min estimate of 570.00 INR. Check if this forecast comes true in a year, meanwhile watch GLENMARK PHARM stock price chart and keep track of the current situation with GLENMARK news and stock market news.
We've gathered opinions of 11 analysts rating GLENMARK stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.